Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PRIMPOL | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
mRNA | DYNLRB1 | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |
mRNA | PAMR1 | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |
mRNA | ITGB5 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |
mRNA | WTAP | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
mRNA | ARL1 | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
mRNA | PCNA | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
mRNA | PBRM1 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
mRNA | TNFRSF12A | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |
mRNA | PHF5A | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |